Ezetrol 10mg tablets Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

ezetrol 10mg tablets

organon pharma (uk) ltd - ezetimibe - oral tablet - 10mg

COZAAR 50MG TABLET Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cozaar 50mg tablet

organon malaysia sdn. bhd. - losartan potassium -

Hyzaar Tablet 50 12.5 mg Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hyzaar tablet 50 12.5 mg

organon malaysia sdn. bhd. - hydrochlorothiazide; losartan potassium -

SINGULAIR TABLET 10MG Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

singulair tablet 10mg

organon malaysia sdn. bhd. - montelukast sodium -

SINGULAIR CHEWABLE TABLET 5MG Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

singulair chewable tablet 5mg

organon malaysia sdn. bhd. - montelukast sodium -

NASONEX AQUEOUS NASAL SPRAY Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nasonex aqueous nasal spray

organon malaysia sdn. bhd. - mometasone furoate -

FORTZAAR TABLET Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fortzaar tablet

organon malaysia sdn. bhd. - hydrochlorothiazide; losartan potassium -

SINGULAIR 4MG CHEWABLE TABLET Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

singulair 4mg chewable tablet

organon malaysia sdn. bhd. - montelukast sodium -

Hyzaar Tablet 100 12.5 mg Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hyzaar tablet 100 12.5 mg

organon malaysia sdn. bhd. - losartan potassium; hydrochlorothiazide, usp, ph. eur. -

SINEMET CR Israel - engelsk - Ministry of Health

sinemet cr

organon pharma israel ltd., israel - carbidopa as monohydrate; levodopa - tablets controlled release - levodopa 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - idiopathic parkinson's disease. postencephalitic parkinsonism. symptomatic parkinsonism. to reduce "off" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration ("wearing-off" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.